Craig W Schlarb, in Bend, OR - Counselor

Craig W Schlarb, is a Counselor - Professional based in Bend, Oregon. Craig W Schlarb is licensed to practice in Oregon (license number C3088) and his current practice location is 2577 Ne Courtney Dr, Bend, Oregon. He can be reached at his office (for appointments etc.) via phone at (541) 322-7500.

NPI number for Craig W Schlarb is 1528186053 and his current mailing address is 2577 Ne Courtney Dr, Bend, Oregon. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1528186053.

Contact Information

	Craig W Schlarb,
	2577 Ne Courtney Dr, Bend, OR 97701-7638
	(541) 322-7500
	(541) 322-7565

Healthcare Provider's Profile

Full Name	Craig W Schlarb
Gender	Male
Speciality	Counselor - Professional
Location	2577 Ne Courtney Dr, Bend, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1528186053
Provider Enumeration Date: 03/26/2007
Last Update Date: 05/18/2016

Medical Identifiers

Medical identifiers for Craig W Schlarb such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528186053	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	PSY20558 (California)	Secondary
101YP2500X	Counselor - Professional	C3088 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Craig W Schlarb is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Craig W Schlarb, 2577 Ne Courtney Dr, Bend, OR 97701-7638 Ph: (541) 322-7500	Craig W Schlarb, 2577 Ne Courtney Dr, Bend, OR 97701-7638 Ph: (541) 322-7500

News Archive

Prognosis brings EHR success to providers across the country

Prognosis Health Information Systems is making good on its mission of bringing electronic health records success to providers across the country.

Debiopharm receives AFSSAPS approval of CTA for Debio 0932 inhibitor, triggers milestone payment to Curis

Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.

DNA methylation can provide effective markers for major cancers, study reveals

In a new study, published online in the July 26 issue of PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective markers for at least four major cancers, not only correctly differentiating malignant tissues from normal, but also providing information on prognosis and survival.

First Edition: February 1, 2010

As President Obama's proposed budget heads to Congress, analysis of the breakdown of health reform - and whether it may still have a chance - continues.

IRIN reports on efforts to increase access to contraceptives, curb population growth in Madagascar

IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."

Craig W Schlarb, - in Bend, OR